Organization Shines Light During National Autoimmune Diseases Awareness Month
Online PR News – 25-March-2011 – – With March being National Autoimmune Diseases Awareness Month, much attention has been brought to the fact that 50 million Americans, or one in five people, suffer from an autoimmune disease. Of that number, 75% are estimated to be women.
With the more than 100 known autoimmune diseases in existence, much research is being done to reduce the social and economic impact and find viable treatment options. According to the American Autoimmune Related Diseases Association (AARDA), autoimmunity is the second leading cause of chronic illness.
However, effective treatments through stem cell procedures are being highlighted as an option from those suffering from certain autoimmune diseases. The International Stem Cell Institute (ISCI) launched the Adult Adipose-derived Stem Cell program last year. Based out of San Diego, the institute is a global advocate of stem cell therapy. Among the ailments being treated include multiple sclerosis (MS), rheumatoid arthritis, and lupus.
“More awareness must be brought to autoimmune diseases and their impact on our society,” said Rita Alexander, president of the International Stem Cell Institute. “It’s important to promote the advancements of stem cell procedures available today. I know firsthand how autoimmune conditions can destroy your life, impact your family and your ability to work. I suffered with rheumatoid arthritis for more than two decades and woke up every day feeling like I had the worst case of the flu and in excruciating pain. My doctors were wonderful, but after trying every medication available there wasn’t anything they could do. Today, I’m living a full life and it was adult stem cell treatment that put this disease in remission. There aren’t words to describe how it feels to recover your health."
ISCI’s physicians use a proprietary Autologous Adult Adipose-derived Stem Cell treatment process developed over the last 6 years by AdiStem Ltd., a world leader in biotechnology. During the procedure, adipose tissue (fat) is removed from the patient using mini-liposuction, and processed with a combination of PRP (platelet rich plasma) which includes growth factors that have a powerful impact on cell development, growth and proliferation. A specialized low laser light is used to activate the stem cells, and is then administered via an IV infusion over a 1-2 hour period of time. The IV infusion is an easy out-patient procedure and an excellent method for treating certain autoimmune diseases such as MS and rheumatoid arthritis.
For more information on Adult Adipose-derived Stem Cell Treatment, please visit the International Stem Cell Institute website at www.iStemCelli.com.